[1] TERUI K, OZAKI M. The role of STAT3 in liver regeneration[J]. Drugs Today, 2005, 41(7):461-469. doi:  10.1358/dot.2005.41.7.893622
[2] FUJIYOSHI M, OZAKI M. Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases[J]. J Hepatobiliary Pancreat Sci, 2011, 18(1):13-22. doi:  10.1007/s00534-010-0304-2
[3] HAGA S, OGAWA W, INOUE H, et al. Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice[J]. J Hepatol, 2005, 43(5):799-807. doi:  10.1016/j.jhep.2005.03.027
[4] WEBBER E M, BRUIX J, PIERCE R H, et al. Tumor necrosis factor primes hepatocytes for DNA replication in the rat[J]. Hepatology, 1998, 28(5):1226-1234. doi:  10.1002/hep.510280509
[5] SEGAWA Y, ITOKAZU Y, INOUE N, et al. Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after concanavalin A-induced hepatic injury[J]. Biol Pharm Bull, 2001, 24(4):425-428. doi:  10.1248/bpb.24.425
[6] HARA H, UCHIDA S, YOSHIMURA H, et al. Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration[J]. Biochim Biophys Acta, 2000, 1492(1):31-44. doi:  10.1016/S0167-4781(00)00056-7
[7] OHTOMI M, NAGAI H, OHTAKE H, et al. Dynamic change in expression of LECT2 during liver regeneration after partial hepatectomy in mice[J]. Biomed Res, 2007, 28(5):247-253. doi:  10.2220/biomedres.28.247
[8] RIZVI F, EVERTON E, SMITH A R, et al. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA[J]. Nat Commun, 2021, 12(1):613. doi:  10.1038/s41467-021-20903-3
[9] LIU X H, QI L W, ALOLGA R N, et al. Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: the need to harness its full potential[J]. Int J Biol Sci, 2022, 18(1):292-300. doi:  10.7150/ijbs.66834
[10] LUO Z M, LEI H, SUN Y, et al. Orosomucoid, an acute response protein with multiple modulating activities[J]. J Physiol Biochem, 2015, 71(2):329-340. doi:  10.1007/s13105-015-0389-9
[11] WANG P Y, FENG J Y, ZHANG Z, et al. The adipokine orosomucoid alleviates adipose tissue fibrosis via the AMPK pathway[J]. Acta Pharmacol Sin, 2022, 43(2):367-375. doi:  10.1038/s41401-021-00666-9
[12] YUAN W, LI G L, ZENG M, et al. Modulation of the blood-brain barrier permeability by plasma glycoprotein orosomucoid[J]. Microvasc Res, 2010, 80(1):148-157. doi:  10.1016/j.mvr.2010.03.011
[13] YUE L, XU X Z, DAI S P, et al. Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization[J]. Sci Rep, 2023, 13(1):14092. doi:  10.1038/s41598-023-40404-1
[14] QIN X Y, HARA M, ARNER E, et al. Transcriptome analysis uncovers a growth-promoting activity of orosomucoid-1 on hepatocytes[J]. EBioMedicine, 2017, 24:257-266. doi:  10.1016/j.ebiom.2017.09.008
[15] NAKAMURA K, ITO I, KOBAYASHI M, et al. Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype[J]. Cytokine, 2015, 73(1):8-15. doi:  10.1016/j.cyto.2015.01.017
[16] MICHALOPOULOS G K, BHUSHAN B. Liver regeneration: biological and pathological mechanisms and implications[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(1):40-55. doi:  10.1038/s41575-020-0342-4
[17] YU J S L, CUI W. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination[J]. Development, 2016, 143(17):3050-3060. doi:  10.1242/dev.137075
[18] SUN Y, LIU W Z, LIU T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis[J]. J Recept Signal Transduct Res, 2015, 35(6):600-604. doi:  10.3109/10799893.2015.1030412
[19] FU M Y, HU Y, LAN T X, et al. The Hippo signalling pathway and its implications in human health and diseases[J]. Signal Transduct Target Ther, 2022, 7(1): 376. ell proliferation during regeneration in rats[J]. J Cell Mol Med, 2020, 24(23): 13679-13689.
[20] GREENHALGH S N, MATCHETT K P, TAYLOR R S, et al. Loss of integrin αvβ8 in murine hepatocytes accelerates liver regeneration[J]. Am J Pathol, 2019, 189(2):258-271. doi:  10.1016/j.ajpath.2018.10.007
[21] CHENG L L, LI X F, DONG W H, et al. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway[J]. J Cancer Res Clin Oncol, 2024, 150(5):230. doi:  10.1007/s00432-024-05720-7
[22] HUMAYUN A, JR FORNACE A J. GADD45 in stress signaling, cell cycle control, and apoptosis[J]. Adv Exp Med Biol, 2022, 1360:1-22.
[23] WANG X P, ZHANG Z D, CAO X L. Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules[J]. Cancer Biol Ther, 2024, 25(1):2322206. doi:  10.1080/15384047.2024.2322206
[24] SOJKA D R, ABRAMOWICZ A, ADAMIEC-ORGANIŚCIOK M, et al. Heat shock protein A2 is a novel extracellular vesicle-associated protein[J]. Sci Rep, 2023, 13(1):4734. doi:  10.1038/s41598-023-31962-5
[25] WU Y, ZHAO J, TIAN Y, et al. Cellular functions of heat shock protein 20(HSPB6)in cancer: A review[J]. Cell Signal, 2023, 112:110928. doi:  10.1016/j.cellsig.2023.110928
[26] LAM Q L, WANG S J, KO O K, et al. Leptin signaling maintains B-cell homeostasis via induction of Bcl-2 and Cyclin D1[J]. Proc Natl Acad Sci U S A, 2010, 107(31):13812-13817. doi:  10.1073/pnas.1004185107
[27] CUI Y Z, HOSUI A, SUN R, et al. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration[J]. Hepatology, 2007, 46(2):504-513. doi:  10.1002/hep.21713
[28] SCHMIDT-ARRAS D, ROSE-JOHN S. IL-6 pathway in the liver: from physiopathology to therapy[J]. J Hepatol, 2016, 64(6):1403-1415. doi:  10.1016/j.jhep.2016.02.004
[29] INABA Y, FURUTANI T, KIMURA K, et al. Growth arrest and DNA damage-inducible 34 regulates liver regeneration in hepatic steatosis in mice[J]. Hepatology, 2015, 61(4):1343-1356. doi:  10.1002/hep.27619
[30] MUELLER K A, GLAJCH K E, HUIZENGA M N, et al. Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells[J]. Sci Rep, 2018, 8(1):11355. doi:  10.1038/s41598-018-29319-4
[31] FU M, PENG D, LAN T, et al. Multifunctional regulatory protein connective tissue growth factor(CTGF): A potential therapeutic target for diverse diseases[J]. Acta Pharm Sin B, 2022, 12(4):1740-60. doi:  10.1016/j.apsb.2022.01.007
[32] CAI W Y, LIN L Y, HAO H, et al. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha(HNF4α)repress reciprocally to regulate hepatocarcinogenesis in rats and mice[J]. Hepatology, 2017, 65(4):1206-1221. doi:  10.1002/hep.28911